Displaying 2151-2200 of 3177 result(s).
Recent Articles
- Soleno Therapeutics Announces Q2 2025 Financial Results Date
- Home Treatment of Bladder Cancer: UroGen's Research Breakthrough
- Vertex Report Highlights Increasing Sales Tax Changes Across U.S.
- Acumen Pharmaceuticals Unveils Promising Developments in Alzheimer's Treatments
- Important Class Action Filing for Sarepta Therapeutics Investors
- Legend Biotech Announces Upcoming Q2 2025 Investor Call
- Market Reactions to US-EU Trade Deal and Performance Insights
- Legal Action Announced Against Replimune Group Over Securities Fraud
- NFI Group Strengthens Commuter Coach Leadership with New Order
- Petco Securities Class Action: Importance of Shareholder Rights
- NetraMark Partners with AlgoTx to Advance Clinical Trials for Pain Relief
- Fortrea Holdings Inc. Faces Class Action Due to Investor Claims
- Great Lakes Dredge & Dock to Announce Q2 2025 Financial Results
- Legend Biotech's Upcoming Investor Call: Q2 2025 Insights
- Integral Metals Begins Drilling Program to Explore Critical Minerals
- Understanding the Securities Class Action Against RxSight, Inc.
- Hyperion DeFi Expands HYPE Holdings to Enhance Investor Engagement
- JDE Peet's Updates Share Buyback: What's Next for Investors?
- Vestis Corporation Faces Class Action Lawsuit Amid Controversies
- Skyline Bankshares, Inc. Reports Strong Financial Performance
- Elevating Travel: New Lease Agreement at Ontario Airport
- Franklin Electric Board Approves Quarterly Dividend of $0.265
- Bell Canada and Cohere Collaborate for Advanced AI Solutions
- Enhancing Cybersecurity: Trend Micro and Google Cloud Unite
- Franklin Electric's Dividend Announcement and Company Insights
- Phathom Pharmaceuticals Announces Upcoming Financial Results Webcast
- Transforming Education: Joel Sackett Joins Frontline Education as CPO
- IMUNON's Stock Dividend Signals Confidence in Growth Strategies
- Servier Unveils Promising Long-Term Findings in AML Treatment
- Legal Alert: Stockholders Target Replimune in Class Action Suit
- Enhancing Alzheimer’s Treatment: NKGen Biotech's Troculeucel Insights
- Cognizant and Lineage Forge Partnership for Enhanced Experiences
- Bullish Analyst Ratings Highlight Top Stocks in Technology
- MARA Holdings Announces Successful $950 Million Note Offering
- HoldCo Asset Management's Bold Proposal for Comerica's Sale
- Maris-Tech Receives $144,000 Defense Order for AI Platform
- Unlocking Monthly Income: Earning $500 from Merck Stock
- Cumulus Neuroscience Unveils Promising Findings on Alzheimer's Data
- Brera Holdings Expands Impact in Football with Multi-Club Strategy
- ATAI Life Sciences and Major Stocks Experience Steep Declines
- EDENA-BEK Group Unveils Pioneering 24/7 Digital Exchange
- Urgent Call for Action: Addressing Homeowners Insurance Crisis
- CreateAI Unveils Animon.ai Studio to Revolutionize Anime Creation
- 3 E Network Technology Group Explores Bitcoin Investment Strategy
- KnowBe4 Secures Spot as Leading Email Security Provider
- CreateAI Revolutionizes Anime Production with Animon.ai Studio
- Z.ai Unveils GLM-4.5: Revolutionizing Open-Source AI Landscape
- BioLife Solutions Strengthens Position with Strategic Investment
- Transforming Workforce Compliance: Veriforce and DISA Unite Forces
- Synchronoss Technologies Sets Date for Q2 Earnings Call